Responses
Friday 07 October 2022 from 13:00 to 14:10
Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics
PO.6.134 Safety and tolerability of nipocalimab administered at different rates of intravenous infusion in healthy adults: a phase 1 placebo-controlled single-dose study
Compose a Response to This Article
Other responses
No responses have been published for this article.